8-methoxy-1,2,3,4-tetrahydro-1,6-naphthyridine, 95.0%, 1g

Ethylenediaminetetraacetic acid, disodium salt dihydrate, ACS reagent, 99%, 50g

3-(3-Fluoro-phenyl)-3-oxo-propionic acid methyl ester, 95.0%, 500mg

iScope IS.1153-PLPH Triocular with Plan phase objectives

(3aS,4S,6R,6aR)-4-(Iodomethyl)-6-methoxy-2,2-dimethyltetrahydrofuro[3,4-d][1,3]dioxole, 95+%, 100mg

(S)-5-Aminopiperidin-2-one hydrochloride, 95.0%, 1g

Didodecyl succinate, 98%, 1g

3-Aminopropyldimethylethoxysilane, 95%, 10g

6-(3,5-Difluorophenyl)picolinic acid, 97%, 1g

4,6-Dibromo-3-hydroxypicolinonitrile, 98%, 5g

2-Ethyl-4,4,5,5-tetramethyl-1,3,2-dioxaborolane, 95.0%, 25g

2'-Deoxy-2'-fluorocytidine hydrate, 95.0%, 5g

CIS-1-BENZYL-5-ETHOXYCARBONYLHEXAHYDROPYRROLO[3,4-B]PYRROLE, 97.0%, 1g